Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...

Oral tablets and injections are both effective ways to ... This medication is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it can help treat type 2 diabetes by prompting your ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a popular glucagon-like peptide 1 (GLP-1) weight loss and ...

Produced by the German company Boehringer Ingelheim, alongside Zealand Pharma, Survodutide is an injectable drug that activates both the glucagon and GLP-1 receptors. According to Nature, the drug is ...

The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

The company is still digging for efficacy signals among subpopulations in the CedLara trial, but has switched its attention to vurolenatide, an injectable glucagon-like peptide-2 (GLP-2 ...

The issuer is solely responsible for the content of this announcement.

The bills, which have advanced in the Senate, would require schools to take certain preventative measures to protect student ...

At normal sugar levels (more than 100 mg/dL), the micelles remain intact, keeping glucagon inactive. Credit Adapted from ACS Central Science 2024, DOI: 10.1021/acscentsci.4c00937 ...